Browsing by Author Sia, Daniela
Showing results 1 to 20 of 20
Issue Date | Title | Author(s) |
---|---|---|
22-Jun-2019 | An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents | Moeini, Agrin; Torrecilla, Sara; Tovar, Victoria; Montironi, Carla; Andreu Oller, Carmen; Peix, Judit; Higuera, Mónica; Pfister, Dominik; Ramadori, Pierluigi; Pinyol, Roser; Solé, Manel; Heikenwälder, Mathias; Friedman, Scott L.; Sia, Daniela; Llovet i Bayer, Josep Maria |
1-Aug-2020 | Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications | Carrillo Reixach, Juan; Torrens, Laura; Simon Coma, Marina; Royo, Laura; Domingo Sàbat, Montserrat; Abril Fornaguera, Jordi; Akers, Nicholas; Sala, Margarita; Ragull, Sonia; Arnal, Magdalena; Villalmanzo, Núria; Cairo, Stefano; Villanueva Garatachea, Alberto; Kappler, Roland; Garrido, Marta; Guerra, Laura; Sabado, Constantino; Guillén, Gabriela; Mallo, Mar; Piñeyro, David; Vázquez Vitali, María; Kuchuk, Olga; Mateos, María Elena; Ramírez, Gema; López Santamaría, Manuel; Mozo, Yasmina; Soriano, Aroa; Grotzer, Michael; Branchereau, Sophie; García de Andoin, Nagore; López Ibor, Blanca; López Almaraz, Ricardo; Salinas, José Antonio; Torres, Bárbara; Hernández, Francisco; Uriz, José Javier; Fabre, Monique; Blanco, Julià; Paris, Claudia; Bajciová, Viera; Laureys, Geneviève; Masnou, Helena; Clos, Ariadna; Belendez, Cristina; Guettier, Catherine; Sumoy, Lauro; Planas, Ramón; Jordà Ramos, Mireia; Nonell, Lara; Czauderna, Piotr; Morland, Bruce; Sia, Daniela; Losic, Bojan; Buendia, Marie Annick; Sarrias Fornés, Maria Rosa; Llovet i Bayer, Josep Maria; Armengol, Carolina |
1-Sep-2017 | Identification of an immune-specific class of Hepatocellular Carcinoma, based on molecular features | Sia, Daniela; Jiao, Yang; Martínez Quetglas, Iris; Kuchuk, Olga; Villacorta Martin, Carlos; de Moura, Manuel Castro; Putra, Juan; Campreciós Figueras, Genís; Bassaganyas, Laia; Akers, Nicholas; Losic, Bojan; Waxman, Samuel; Thung, Swan N.; Mazzaferro, Vincenzo; Esteller, Manel; Friedman, Scott L.; Schwartz, Myron; Villanueva, Augusto; Llovet i Bayer, Josep Maria |
7-Jan-2019 | Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC | Pinyol, Roser; Sia, Daniela; Llovet i Bayer, Josep Maria |
Nov-2021 | Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma. | Torrens, Laura; Montironi, Carla; Puigvehí, Marc; Mesropian, Agavni; Leslie, Jack; Haber, Philipp K.; Maeda, Miho; Balaseviciute, Ugne; Willoughby, Catherine E.; Abril Fornaguera, Jordi; Piqué Gili, Marta; Torres Martín, Miguel; Peix, Judit; Geh, Daniel; Ramon Gil, Erik; Saberi, Behnam; Friedman, Scott L.; Mann, Derek A.; Sia, Daniela; Llovet i Bayer, Josep Maria |
15-Jan-2020 | Intratumoral heterogeneity and clonal evolution in liver cancer | Losic, Bojan; Craig, Amanda J.; Villacorta-Martin, Carlos; Martins-Filho, Sebastiao N.; Akers, Nicholas; Chen, Xintong; Ahsen, Mehmet Eren; von Felden, Johann; Labgaa, Ismail; Avola, Delia D'; Allette, Kimaada; Lira, Sergio A.; Furtado, Glaucia C.; Garcia-Lezana, Teresa; Restrepo, Paula; Stueck, Ashley; Ward, Stephen C.; Fiel, Maria I.; Hiotis, Spiros P.; Gunasekaran, Ganesh; Sia, Daniela; Schadt, Eric E.; Sebra, Robert; Schwartz, Myron; Llovet i Bayer, Josep Maria; Thung, Swan N.; Stolovitzky, Gustavo; Villanueva, Augusto |
Mar-2016 | Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis | Sia, Daniela; Villanueva, Augusto; Friedman, Scott L.; Llovet i Bayer, Josep Maria |
23-Jan-2017 | Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity | Moeini, Agrin; Sia, Daniela; Zhang, Zhongyang; Campreciós Figueras, Genís; Stueck, Ashley; Dong, Hui; Montal, Robert; Torrens, Laura; Martínez Quetglas, Iris; Fiel, Maria Isabel; Hao, Ke; Villanueva, Augusto; Thung, Swan N.; Schwartz, Myron; Llovet i Bayer, Josep Maria |
13-May-2021 | Molecular characterization of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis | Pinyol, Roser; Torrecilla, Sara; Wang, Huan; Montironi, Carla; Piqué Gili, Marta; Torres Martín, Miguel; Wei-Qiang, Leow; Willoughby, Catherine E.; Ramadori, Pierluigi; Andreu Oller, Carmen; Taik, Patricia; Lee, Youngmin A.; Moeini, Agrin; Peix, Judit; Faure-Dupuy, Suzanne; Riedl, Tobias; Schuehle, Svenja; Oliveira, Claudia P.; Alves, Venancio A.; Boffetta, Paolo; Lachenmayer, Anja; Roessler, Sthephanie; Minguez, Beatriz; Schirmacher, Peter; Dufour, Jean François; Thung, Swan N.; Reeves, Helen L.; Carrilho, Flair J.; Chang, Charissa; Uzilov, Andrew V.; Heikenwalder, Mathias; Sanyal, Arun; Friedman, Scott L.; Sia, Daniela; Llovet i Bayer, Josep Maria |
9-Jul-2019 | Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials | Montal, Robert; Andreu Oller, Carmen; Bassaganyas, Laia; Esteban Fabró, Roger; Moran, Sebastian; Montironi, Carla; Moeini, Agrin; Pinyol, Roser; Peix, Judit; Cabellos, Laia; Villanueva, Augusto; Sia, Daniela; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria |
1-Jun-2018 | Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial | Pinyol, Roser; Montal, Robert; Bassaganyas, Laia; Sia, Daniela; Takayama, Tadatoshi; Chau, Gar-Yang; Mazzaferro, Vincenzo; Roayaie, Sasan; Lee, Han Chu; Kokudo, Norihiro; Zhang, Zhongyang; Torrecilla, Sara; Moeini, Agrin; Rodriguez-Carunchio, Leonardo; Gane, Edward; Verslype, Chris; Croitoru, Adina Emilia; Cillo, Umberto; de la Mata, Manuel; Lupo, Luigi; Strasser, Simone; Park, Joong-Won; Camps, Jordi; Solé, Manel; Thung, Swan N.; Villanueva, Augusto; Pena, Carol; Meinhardt, Gerold; Bruix Tudó, Jordi; Llovet i Bayer, Josep Maria |
30-Jul-2018 | Molecular therapies and precision medicine for hepatocellular carcinoma | Llovet i Bayer, Josep Maria; Montal, Robert; Sia, Daniela; Finn, Richard S. |
2-Jul-2014 | Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer | Saha, Supriya K.; Parachoniak, Christine A.; Ghanta, Krishna S.; Fitamant, Julien; Ross, Kenneth N.; Najem, Mortada S.; Gurumurthy, Sushma; Akbay, Esra A.; Sia, Daniela; Cornella, Helena; Miltiadous, Oriana; Walesky, Chad; Deshpande, Vikram; Zhu, Andrew X.; Hezel, Aram F.; Yen, Katharine E.; Straley, Kimberly S.; Travins, Jeremy; Popovici-Muller, Janeta; Gliser, Camelia; Ferrone, Cristina R.; Apte, Udayan; Llovet i Bayer, Josep Maria; Wong, Kwok-Kin; Ramaswamy, Sridhar; Bardeesy, Nabeel |
14-Nov-2016 | Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma | Bollard, Julien; Miguela, Verónica; Ruiz de Galarreta, Marina; Venkatesh, Anu; Bian, C. Billie; Roberto, Mark P.; Tovar, Victoria; Sia, Daniela; Molina Sánchez, Pedro; Nguyen, Christie B.; Nakagawa, Shigeki; Llovet i Bayer, Josep Maria; Hoshida, Yujin; Lujambio, Amaia |
Dec-2015 | Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation. | Miltiadous, Oriana; Sia, Daniela; Hoshida, Yujin; Fiel, Maria Isabel; Harrington, Andrew N.; Thung, Swan N.; Seng Tan, Poh; Dong, Hui; Revill, Kate; Chang, Charissa Y.; Roayaie, Sasan; Byrne, Thomas J.; Mazzaferro, Vincenzo; Rakela, Jorge; Florman, Sander; Schwartz, Myron; Llovet i Bayer, Josep Maria |
24-Jun-2021 | Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. | Craig, Amanda J.; Garcia-Lezana, Teresa; Ruiz de Galarreta, Marina; Villacorta-Martin, Carlos; Kozlova, Edgard G; Martins-Filho, Sebastiao N.; von Felden, Johann; Ahsen, Mehmet Eren; Bresnahan, Erin; Hernandez Meza, Gabriela; Labgaa, Ismail; D'Avola, Delia; Schwartz, Myron; Llovet i Bayer, Josep Maria; Sia, Daniela; Thung, Swan N.; Losic, Bojan; Lujambio, Amaia; Villanueva, Augusto |
2-Aug-2017 | Translating '–omics' results into precision medicine for hepatocellular carcinoma | Sia, Daniela; Llovet i Bayer, Josep Maria |
24-Aug-2017 | Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma | Torrecilla, Sara; Harrington, Andrew N.; Sia, Daniela; Zhang, Zhongyang; Cabellos, Laia; Cornella, Helena; Moeini, Agrin; Campreciós Figueras, Genís; Leow, Wei-Quiang; Fiel, Maria Isabel; Hao, Ke; Bassaganyas, Laia; Mahajan, Milind; Thung, Swan N.; Villanueva, Augusto; Florman, Sander; Schwartz, Myron; Llovet i Bayer, Josep Maria |
1-Mar-2017 | Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma | Tovar, Victoria; Cornella, Helena; Moeini, Agrin; Vidal, Samuel; Hoshida, Yujin; Sia, Daniela; Peix, Judit; Cabellos, Laia; Alsinet, Clara; Torrecilla, Sara; Martínez Quetglas, Iris; Lozano Salvatella, Juan José; Desbois-Mouthon, Christele; Sole, Manel; Domingo Domènech, Josep Maria; Villanueva, Augusto; Llovet i Bayer, Josep Maria |
17-Mar-2015 | YAP Inhibition restores Hepatocyte differentiation in advanced HCC, leading to tumor regression | Fitamant, Julien; Kottakis, Filippos; Benhamouche, Samira; Tian, Helen S.; Chuvin, Nicolas; Parachoniak, Christine A.; Nagle, Julia M.; Perera, Rushika M.; Lapouge, Marjorie; Deshpande, Vikram; Zhu, Andrew X.; Lai, Albert; Min, Bosun; Hoshida, Yujin; Avruch, Joseph; Sia, Daniela; Campreciós Figueras, Genís; McClatchey, Andrea I.; Llovet i Bayer, Josep Maria; Morrissey, David; Raj, Lakshmi; Bardeesy, Nabeel |